The Big Business Behind Weight Loss Drugs
Listen now
Description
It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sanjay Gupta turns to his CNN colleague Meg Tirrell for answers, and a little context about the business behind these new medications.
Learn more about your ad choices. Visit podcastchoices.com/adchoices
More Episodes
The U.S. is grappling with a recently discovered outbreak of avian influenza in dairy cows, driven by the highly pathogenic H5N1 virus. It's the first instance that the bird flu virus has been detected in US cattle. How concerned should we be about drinking milk or even eating chicken? And could...
Published 04/30/24
Published 04/30/24
Global temperatures are rising, severe storms are intensifying and people are feeling climate anxiety. Does saving the planet mean living without comfort or convenience? Can policies and technology turn things around? CNN Chief Climate Correspondent, Bill Weir believes taking better care of the...
Published 04/23/24
Links
Genres
Artwork or description wrong?
Request an update »
Updates may take a few minutes.
Do you host a podcast?
Track your ranks and reviews from Spotify, Apple Podcasts and more.
See hourly chart positions and more than 30 days of history.
Get Chartable Analytics »
See hourly chart positions and more than 30 days of history.
